01 3ALISKIREN HEMIFUMARATE
02 4ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
03 2Aliskiren Hemifumarate
04 4Aliskiren Hemifumarate and Hydrochlorothiazide
05 2Aliskiren hemifumarate
06 8Aliskireno
07 1COCAINE HYDROCHLORIDE
08 4Hydrochlorothiazide; Aliskirene
01 8NODEN PHARMA
02 12Noden Pharma Designated Activity Company
03 2The Pharma DAC node
04 6The Pharma Dac Node
01 1CAPSULE, PELLET;ORAL
02 20Film Coated Tablet
03 1SOLUTION;NASAL
04 6TABLET;ORAL
01 4150MG
02 1150MG; 12.5 MG
03 1150MG; 25 MG
04 2150mg
05 1150mg;12.5mg
06 1150mg;25mg
07 4300MG
08 1300MG; 12.5 MG
09 1300MG; 25 MG
10 2300mg
11 1300mg;12.5mg
12 1300mg;25mg
13 14%
14 1EQ 150MG BASE
15 1EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
16 1EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
17 1EQ 300MG BASE
18 1EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 1EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
20 1EQ 37.5MG BASE
01 2Norway
02 12Spain
03 6Sweden
04 8USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : TEKTURNA
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2007-03-05
Application Number : 21985
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : TEKTURNA
Dosage Strength : EQ 300MG BASE
Packaging :
Approval Date : 2007-03-05
Application Number : 21985
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE, PELLET;ORAL
Brand Name : TEKTURNA
Dosage Strength : EQ 37.5MG BASE
Packaging :
Approval Date : 2017-11-14
Application Number : 210709
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Brand Name : Rasilez
Dosage Strength : 150mg
Packaging :
Approval Date : 22/08/2007
Application Number : 20061009000013
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Brand Name : Rasilez
Dosage Strength : 300mg
Packaging :
Approval Date : 22/08/2007
Application Number : 20061009000020
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Not Marketed
Registration Country : Norway
Dosage Form : Film Coated Tablet
Brand Name : Rasilez
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Not Marketed
Registration Country : Norway
Dosage Form : Film Coated Tablet
Brand Name : Rasilez
Dosage Strength : 300mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Deregistered
Registration Country : Sweden
Aliskiren Hemifumarate And Hydrochlorothiazide
Dosage Form : Film Coated Tablet
Brand Name : Rasilezhct
Dosage Strength : 150mg;12.5mg
Packaging :
Approval Date : 16/01/2009
Application Number : 20080123000037
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Aliskiren Hemifumarate And Hydrochlorothiazide
Dosage Form : Film Coated Tablet
Brand Name : Rasilezhct
Dosage Strength : 150mg;25mg
Packaging :
Approval Date : 16/01/2009
Application Number : 20080123000044
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Aliskiren Hemifumarate And Hydrochlorothiazide
Dosage Form : Film Coated Tablet
Brand Name : Rasilezhct
Dosage Strength : 300mg;12.5mg
Packaging :
Approval Date : 16/01/2009
Application Number : 20080123000051
Regulatory Info : Deregistered
Registration Country : Sweden
